Westerman DA - Search Results

1

Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib.

Ritchie DS, McBean M, Westerman DA, Kovalenko S, Seymour JF, Dobrovic A. Ritchie DS, et al. Among authors: westerman da. Blood. 2008 Mar 1;111(5):2896-8. doi: 10.1182/blood-2007-08-107508. Epub 2007 Dec 11. Blood. 2008. PMID: 18073350 Free article.

2

Paraffin section immunotyping of leukaemias.

Juneja S, Trute L, Westerman D, Venter D, Seymour JF, Prince HM. Juneja S, et al. Br J Haematol. 2000 May;109(2):267-71. doi: 10.1046/j.1365-2141.2000.01919.x. Br J Haematol. 2000. PMID: 10848811 Free article. Review. No abstract available.

3

CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy.

Prince HM, Wall D, Rischin D, Toner GC, Seymour JF, Blakey D, Haylock D, Simmons P, Wolf M, Januszewicz EH, Westerman D, Richardson G, Scarlett J, Briggs P. Prince HM, et al. Cytotherapy. 2002;4(2):147-55. doi: 10.1080/146532402317381857. Cytotherapy. 2002. PMID: 12006210 Clinical Trial.

4

A case of clinical indolent natural killer cell lineage large granular lymphocytic leukemia in a patient with rheumatoid arthritis.

Machatschek JN, Westerman D, Prince HM, Seymour JF. Machatschek JN, et al. Leuk Lymphoma. 2003 Jul;44(7):1223-7. doi: 10.1080/1042819031000079203. Leuk Lymphoma. 2003. PMID: 12916876 Review.

5

Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.

Tam CS, Wolf MM, Januszewicz EH, Prince HM, Westerman D, Seymour JF. Tam CS, et al. Cancer. 2004 May 15;100(10):2181-9. doi: 10.1002/cncr.20234. Cancer. 2004. PMID: 15139062 Free article. Review.

6

Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.

Tam CS, Prince HM, Westerman D, Seymour JF, Juneja S. Tam CS, et al. Leuk Lymphoma. 2004 Apr;45(4):705-10. doi: 10.1080/10428190310001615657. Leuk Lymphoma. 2004. PMID: 15160943 Review.

7

Confirmation of the activity of the interleukin-2 fusion toxin denileukin diftitox against chemorefractory chronic lymphocytic leukemia, including cases with chromosome 17p deletions and without detectable CD25 expression.

Morgan SJ, Seymour JF, Prince HM, Westerman DA, Wolf MM. Morgan SJ, et al. Among authors: westerman da. Clin Cancer Res. 2004 May 15;10(10):3572-5. Clin Cancer Res. 2004. PMID: 15161717 No abstract available.

8

A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies.

Tam CS, Wolf MM, Januszewicz EH, Grigg AP, Prince HM, Westerman D, Seymour JF. Tam CS, et al. Cancer. 2004 Nov 1;101(9):2042-9. doi: 10.1002/cncr.20615. Cancer. 2004. PMID: 15372472 Free article.

9

Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy.

Brennand S, Sutton VR, Biagi J, Trapani JA, Westerman D, McCormack CJ, Seymour JF, Kennedy G, Prince HM. Brennand S, et al. Br J Dermatol. 2005 Jun;152(6):1199-205. doi: 10.1111/j.1365-2133.2005.06539.x. Br J Dermatol. 2005. PMID: 15948982

10

Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T-cell lymphoproliferative disorders.

Gibbs SD, Westerman DA, McCormack C, Seymour JF, Miles Prince H. Gibbs SD, et al. Among authors: westerman da. Br J Haematol. 2005 Jul;130(1):87-91. doi: 10.1111/j.1365-2141.2005.05570.x. Br J Haematol. 2005. PMID: 15982349 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters